Wang Xiu, Bai Xue, Jin Chengcheng, Zhao Liqiong, Wei Ruihua
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Fukang Road 251, Nankai District, Tianjin 300384, China.
J Ophthalmol. 2022 Mar 14;2022:1910607. doi: 10.1155/2022/1910607. eCollection 2022.
To analyze tear function outcomes following collagen cross-linking (CXL) treatment in ectatic corneas.
Fifty-seven eyes of 34 patients were included, and patients with keratoconus who underwent epithelium-on (epi-on) or epithelium-off (epi-off) CXL were evaluated. The following tests were performed preoperatively and at 1, 3, 6, and 12 months postoperatively: best-corrected visual acuity (BCVA), maximum keratometry value (Kmax), ocular surface disease index (OSDI) questionnaire, slit-lamp examination, tear meniscus height, first noninvasive Keratograph breakup time (1st NIKBUT), average NIKBUT, and bulbar redness.
BCVA improved in both epi-on and epi-off groups at most follow-up points, but was not significantly different between groups. At 12-month follow-up, Kmax in the epi-on and epi-off groups improved after CXL, but there was no significant difference between the groups. The OSDI in both groups decreased after operation compared with before surgery, and there was no significant difference between the two groups. Comparing the two groups, only the change in the tear meniscus height at 6 months postoperatively was statistically significant, and the pre- and postoperative values of the two groups were within the normal range (>0.20 mm). The change was small and had no clinical significance. There was no change in the 1st NIKBUT and average NIKBUT between the epi-on and epi-off groups. A change in bulbar redness was significantly better in the epi-off group than in the epi-on group at 3 months postoperatively. Comparing the effects at 1 year postoperatively, both groups had positive results in OSDI, NIKBUT, tear meniscus height, and bulbar redness.
Both epi-on and epi-off CXL can control the progression of keratoconus, although epi-off CXL is more effective. Both methods have a positive effect on dry eye, which can improve the condition of the tear film and reduce dry eye symptoms in patients with keratoconus.
分析角膜扩张症患者接受胶原交联(CXL)治疗后的泪液功能结果。
纳入34例患者的57只眼,对接受上皮在位(epi-on)或上皮去除(epi-off)CXL的圆锥角膜患者进行评估。在术前以及术后1、3、6和12个月进行以下检查:最佳矫正视力(BCVA)、最大角膜曲率值(Kmax)、眼表疾病指数(OSDI)问卷、裂隙灯检查、泪河高度、首次无创角膜地形图破裂时间(1st NIKBUT)、平均NIKBUT以及球结膜充血。
在大多数随访点,epi-on组和epi-off组的BCVA均有改善,但两组之间无显著差异。在12个月随访时,epi-on组和epi-off组的Kmax在CXL后均有改善,但两组之间无显著差异。与术前相比,两组术后的OSDI均降低,且两组之间无显著差异。比较两组,仅术后6个月时泪河高度的变化具有统计学意义,且两组术前和术后的值均在正常范围内(>0.20 mm)。变化较小,无临床意义。epi-on组和epi-off组之间的1st NIKBUT和平均NIKBUT无变化。术后3个月时,epi-off组球结膜充血的改善明显优于epi-on组。比较术后1年的效果,两组在OSDI、NIKBUT、泪河高度和球结膜充血方面均有阳性结果。
epi-on和epi-off CXL均可控制圆锥角膜的进展,尽管epi-off CXL更有效。两种方法对干眼均有积极作用,可改善泪膜状况并减轻圆锥角膜患者的干眼症状。